Literature DB >> 17225915

Löffler endocarditis without peripheral eosinophilia.

G H Wasmeier, D Ropers, A Dimmler, T Fischlein, W G Daniel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17225915     DOI： 10.1007/s00392-007-0483-2

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  7 in total

Review 1.  Mechanisms of eosinophil-associated inflammation.

Authors:  G J Gleich
Journal:  J Allergy Clin Immunol       Date:  2000-04       Impact factor: 10.793

2.  [Löffler fibroblastic endocarditis in the thrombotic stages in isolated right ventricular tissue eosinophilia].

Authors:  A Hagendorff; M Hümmelgen; H Omran; L Pizzulli; M Zirbes; E Bierhoff; T Sommer; U Pfeifer; P G Kirchhoff; J Nitsch; B Lüderitz
Journal:  Z Kardiol       Date:  1998-04

Review 3.  Hypereosinophilic syndrome: an update.

Authors:  H Jeffrey Wilkins; Martin M Crane; Kelly Copeland; William V Williams
Journal:  Am J Hematol       Date:  2005-10       Impact factor: 10.047

Review 4.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

Review 5.  The idiopathic hypereosinophilic syndrome.

Authors:  P F Weller; G J Bubley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

Review 6.  [Prognostic factors of hypereosinophilic syndrome. Study of 40 cases].

Authors:  C Lefebvre; O Bletry; P Degoulet; L Guillevin; M Bentata-Pessayre; D u Le Thi Huong; P Godeau
Journal:  Ann Med Interne (Paris)       Date:  1989

7.  The idiopathic hypereosinophilic syndrome: clinical presentation, pathogenesis and therapeutic strategies.

Authors:  F Roufosse; E Bartholomé; L Schandené; M Goldman; E Cogan
Journal:  Drugs Today (Barc)       Date:  1998-04       Impact factor: 2.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.